Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 5/2019

01-09-2019 | Conservative Therapy | Original Article

Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw

Authors: Yuka Kojima, Yumi Kawaoka, Shunsuke Sawada, Saki Hayashida, Kohei Okuyama, Hirokazu Yutori, Akiko Kawakita, Suguru Ishida, Sakiko Soutome, Souichi Yanamoto, Masahiro Umeda, Hiroshi Iwai

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2019

Login to get access

Abstract

Regarding treatment strategies for medication-related osteonecrosis of the jaw (MRONJ), surgical therapy has recently been reported to be more effective than conservative therapy. However, some patients did not achieve complete healing, even when extensive surgery was performed. Periosteal reaction in MRONJ patients is often observed by the CT examination. Tssshe purpose of this study was to investigate the relationship between periosteal reaction and treatment outcome of MRONJ. A total of 164 surgeries in 136 patients with MRONJ at two hospitals were included in the study. Correlations between various clinical and radiographic factors and treatment outcome were examined with Cox regression analysis. The results showed that the presence of periosteal reaction, as well as primary disease involving malignant tumor, were independent risk factors related to poor outcome. Furthermore, we examined factors related to the occurrence of the periosteal reaction and found that 4 variables were significantly correlated with periosteal reaction by multivariate analysis: gender (female), site (lower jaw), primary disease (malignant tumor), and osteosclerosis (severe). The present study clarified that the cure rate after surgical treatment decreased in cases with periosteal reaction, suggesting that it is necessary to review the treatment method.
Literature
1.
go back to reference Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117CrossRefPubMed Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117CrossRefPubMed
2.
go back to reference Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRefPubMed
3.
go back to reference Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28:365–383CrossRefPubMed Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28:365–383CrossRefPubMed
4.
go back to reference Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, Di Lenarda R, Biasotto M (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50:1049–1057CrossRefPubMed Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, Di Lenarda R, Biasotto M (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50:1049–1057CrossRefPubMed
5.
go back to reference Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S (2015) Treatment strategies and outcome of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg 44:568–585CrossRefPubMed Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S (2015) Treatment strategies and outcome of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg 44:568–585CrossRefPubMed
6.
go back to reference Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23CrossRefPubMed Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23CrossRefPubMed
7.
go back to reference Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakhara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: A multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022–2029CrossRefPubMed Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakhara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: A multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022–2029CrossRefPubMed
8.
go back to reference Fatterpekar GM, Emmrich JV, Eloy JA, Aggarwal A (2011) Bone-within-bone appearance: A red flag for bisphosphonate-associated osteonecrosis of the jaw. J Comput Assist Tomogr 35:553–556CrossRefPubMed Fatterpekar GM, Emmrich JV, Eloy JA, Aggarwal A (2011) Bone-within-bone appearance: A red flag for bisphosphonate-associated osteonecrosis of the jaw. J Comput Assist Tomogr 35:553–556CrossRefPubMed
9.
go back to reference Guo Y, Wang D, Wang Y, Peng X, Guo C (2016) Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol 122:e69–76CrossRefPubMed Guo Y, Wang D, Wang Y, Peng X, Guo C (2016) Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol 122:e69–76CrossRefPubMed
12.
go back to reference Ida M, Tetsumura A, Kurabayashi T, Sasaki T (1997) Periosteal new bone formation in the jaws. A computed tomographic study. Dentomaxillofac Radiol 26:169–176CrossRefPubMed Ida M, Tetsumura A, Kurabayashi T, Sasaki T (1997) Periosteal new bone formation in the jaws. A computed tomographic study. Dentomaxillofac Radiol 26:169–176CrossRefPubMed
13.
go back to reference Akashi M, Wanifuchi S, Iwata E, Takeda D, Kusumoto J, Furudoi S, Komori T (2016) Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw. Oral Maxillofac Surg 22:59–63CrossRef Akashi M, Wanifuchi S, Iwata E, Takeda D, Kusumoto J, Furudoi S, Komori T (2016) Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw. Oral Maxillofac Surg 22:59–63CrossRef
Metadata
Title
Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw
Authors
Yuka Kojima
Yumi Kawaoka
Shunsuke Sawada
Saki Hayashida
Kohei Okuyama
Hirokazu Yutori
Akiko Kawakita
Suguru Ishida
Sakiko Soutome
Souichi Yanamoto
Masahiro Umeda
Hiroshi Iwai
Publication date
01-09-2019
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2019
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-019-00994-1

Other articles of this Issue 5/2019

Journal of Bone and Mineral Metabolism 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.